ARCHIVES

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

Panel To Look At Cancer Centers Program, Starting With West Coast, Hawaii Meetings This Year, Next

January 27, 1984

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978